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Psssst, Bacteria are Talking
PAGE 1141
Bacterial populations use quorum sensing (QS) to coordinate their behavior and execute a number of functions according to the density of
their population. This phenomenon of intercellular communication is mediated by different classes of small molecules, including N-acylho-
moserine lactones. This minireview by Cooley et al. discusses the most recent findings that some soild bacteria have the ability to employ
host-derived compounds and produce alternativeN-acylhomoserine lactones. Additionally, this minireview discusses the recently described
mechanism of how N-acylhomoserine lactones affect host inflammatory signaling pathways to promote bacterial survival.
Modulating Intrinsic Disorder
PAGE 1149
Several small molecules that disrupt c-Myc-Max heterodimerization act by specifically binding c-Myc and thus stabilizing the intrinsically dis-
ordered (ID) proteinmonomers over the highly ordered heterodimer. The characteristics of sites within an ID region capable of specific binding
by small molecules were unknown. Here, Follis et al. describe the interactions of two small molecules that form soluble, reversible complexes
with c-Myc. These findings suggest that potential binding sites may be prevalent in ID proteins and that the discovery of small molecules
capable of modulating the functions of these proteins may be practicable. (Figure adapted from Follis et al.)
Protein-Protein Interactions within the Type II PKS Complex
PAGE 1156
Myriads of biological processes depend on the dynamic protein/protein and protein/ligand interactions. In metabolic pathways, enzymes cat-
alysing sequential reactions often transiently associate to increase reaction rates and protect labile intermediates by channelling themdirectly
from one active site to another. Castaldo et al. now investigate complex protein interactions involved in the biosynthesis of the aromatic poly-
ketide components of daunorubicin, an anticancer drug, using a yeast two-hybrid system, tandem affinity purification, and computer simu-
lation. The approach resulted in gaining valuable insight into the protein-protein interactions within the type II PKS complex, which might lead
to improved set of design rules for the synthesis of aromatic polyketides through combinatorial biosynthesis.
Wagging Histone H3 Tails
PAGE 1166
By redefining the genetic code, one canmake the ribosome incorporate nonproteinogenic
amino acids into peptides according to information encoded in mRNAs. Using this
genetic code reprogramming, Kang et al. have prepared a series of N-terminal tails of his-
tone H3 containing combinatorial lysine modifications, including mono-, di-, and tri-meth-
ylation and acetylation. The full-length 38-mer H3 tails with distal combinatorial modifica-
tion enabled Kang et al. to reveal the possible crosstalk among epigenetic markers upon
HP1 chromodomain binding. Thus, the approach described here could be a general tool
to investigate lysine modification-protein interaction relationships. (Figure provided by
Kang et al.)
Microbial Symbiont Investigated
PAGE 1175
Many pharmacologically active natural products are generated by microbial symbionts of
marine invertebrates. In most cases, these microorganisms remain refractory to cultiva-
tion, and thus gene disruptionmethods cannot be employed to establish that a sequenced
biosynthetic cluster specifies production of a particular secondary metabolite. In this
study, Lopanik et al. demonstrate that several of the genes from the putative bry biosyn-
thetic system responsible for assembly of the bryostatins, polyketidemetabolites with anticancer and neurological activity, operate according
to their hypothesized role based on in vitro biochemical analysis and genetic complementation in a heterologous host. This work illustrates the
power of combined approaches to provide important insights into enzyme function of complex microbial symbiont-derived biosynthetic
systems.Chemistry & Biology 15, November 24, 2008 ª2008 Elsevier Ltd All rights reserved ix
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Yanagisawa et al. report here a method to incorporate a nonnatural, chemically reactive amino acid, N3-(o-azidobenzyloxycarbonyl)-L-lysine
(AzZLys), site specifically into proteins in Escherichia coli cells.Methanosarcina mazei pyrrolysyl-tRNA synthetase (PylRS) esterified an amber
suppressor tRNA (tRNAPyl) with several nonnatural lysine derivatives, in addition to the natural substrate pyrrolysine. Some of the lysine
derivatives were incorporated into proteins by a mutant PylRSdtRNAPyl. Then, structure-based and random mutagenesis of PylRS enabled
10 mg-scale production of proteins that contain AzZLys site specifically. The AzZLys residue in the produced protein can be modified with
a fluorescent label, more efficiently than the p-azido-L-phenylalanine residue with a shorter side chain.
Improved Anti-Fungal Polyene Macrolides
PAGE 1198
Efficient and safe antifungal agents are urgently needed due to the grow-
ing number of life-threatening systemic fungal infections. Brautaset et al.
generated new analogs of the polyene macrolide antibiotic nystatin using
biosynthetic engineering and tested the obtained compounds for antifun-
gal activity and toxicity both in vitro and in vivo. Two nystatin analogs were
shown to be effective in treatment of disseminated candidosis in mice,
while being considerably less toxic compared to amphotericin B, the
only polyene macrolide currently used for treatment of systemic fungal in-
fections. The two analogs might therefore represent promising lead com-
pounds for further development of antifungal drugs for human therapy.
Structural Requirements for Cannabinoid Receptor Binding
PAGE 1207
Activity of the CB2 cannabinoid receptor has been implicated to be of benefit in neuropathic pain, inflammation, and immune disorders. Thus,
small-molecule ligands that bind to and activate the CB2 receptor have promise as potential therapeutics for these and other disorders. In
order to design ligands that are potent and selective for the CB2 receptor without inducing off-target effects, it is important to understand
the ligand-binding architecture of the CB2 receptor. By using a ‘‘ligand-assisted protein structure’’ experimental approach, this work by
Pei et al. helps characterize directly the structural requirements for ligand binding to the human CB2 receptor critical to pharmacotherapeutic
CB2 receptor modulation.
Isoform Specific Activators of AMPK
PAGE 1220
The AMP-activated protein kinase (AMPK) is a key player in the regulation of
cellular and whole-body energy balance and is now recognized as a promising
target for new drugs to fight the growing epidemic of obesity and Type 2 diabe-
tes. The thienopyridone drug A769662 has been shown to activate AMPK by
an AMP-independent mechanism, revealing the existence of an alternate regu-
latory site. In this study, Scott et al. demonstrate that A769662 selectively
activates specific isoforms of AMPK, highlighting the feasability of developing
isoform-specific activators of AMPK that can target AMPK in particular tissues.
(Figure adapted from Scott et al.)
Stereochemistry of Enoylreduction in
Modular PKS
PAGE 1231
When an enoylreductase (ER) enzyme of a modular polyketide synthase (PKS)
reduces a propionate extender unit that has been newly added to the growing
polyketide chain, the resulting methyl branch may have either S- or R-configuration. Kwan et al. have now uncovered a correlation between
the presence or absence of a unique tyrosine (Y) residue in the ER active site and the chirality of themethyl branch that is introduced.When this
position in the active site is occupied by Y, the methyl branch has S-configuration, otherwise it has R- configuration. Thus, a mutation (Y to
valine [V]) in an erythromycin PKS-derived ER caused a switch from S- to R-. However, V to Y mutation in a rapamycin-derived PKS ER was
insufficient to achieve a switch from R- to S-, suggesting that additional residues also participate in stereocontrol of enoylreduction.x Chemistry & Biology 15, November 24, 2008 ª2008 Elsevier Ltd All rights reserved
